← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
130 ta ish
Ish: Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dai Fukumura, Jonas Kloepper, Zohreh Amoozgar +2
Sharh maqolaOchiq kirish20183 iqtibosABIAnti-angiogenesis therapy overcomes the innate resistance to PD-1/PD-L1 blockade in VEGFA-overexpressed mouse tumor models
Qiaohong Wang, Jingze Gao, Wen Di +1
MaqolaOchiq kirish20202 iqtibosABIAnti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
Zowi R. Huinen, Elisabeth J. M. Huijbers, Judy R. van Beijnum +2
Sharh maqolaOchiq kirish20212 iqtibosABICombined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
Elizabeth Allen, Arnaud Jabouille, Lee B. Rivera +8
MaqolaOchiq kirish20172 iqtibosABIMMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Lisa M. Coussens, Christopher L. Tinkle, Douglas Hanahan +1
MaqolaOchiq kirish20002 iqtibosABINanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives
Ruixue Zhang, Ho Lun Wong, Hui Xue +2
Sharh maqola20162 iqtibosABINormalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Sharh maqola20132 iqtibosABIRadiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
James A. Bonner, Paul M. Harari, J. Giralt +14
Maqola20062 iqtibosABIAtezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo +17
Maqola20182 iqtibosABI